The SPDR S&P Pharmaceuticals ETF received Form 13F filings regarding institutional holdings with the Securities and Exchange Commission on May 27, 2026.
3 reports, 2 independent
Updated May 27
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The SPDR S&P Pharmaceuticals ETF received Form 13F filings regarding institutional holdings with the Securities and Exchange Commission on May 27, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.SPDR S&P Pharmaceuticals ETF filed 13F reports with the SEC on May 27, 2026.1 source
McKesson Corporation filed 13F reports regarding institutional holdings.1 source
Keep exploring
The entities involved
-
Securities and Exchange Commission
government agency of the Philippines
-
McKesson Corporation
U.S. healthcare supplies
Nothing else this week.
Related events
- A Short-Term Bond ETF has filed its required 13F reports regarding institutional holdings with the Securities and Exchange Commission.
- Corning submitted required 13F filings regarding institutional holdings to the Securities and Exchange Commission on June 6, 2026.
- SEC requires Form 13F filings for the Capital Group Core Balanced ETF.
- The SEC requires institutional investors to file 13F reports for the JPMorgan International Research Enhanced Equity ETF.
- The SEC requires the filing of institutional holdings data for the Schwab U.S. Large-Cap Value ETF.